0001567619-19-018220.txt : 20190912
0001567619-19-018220.hdr.sgml : 20190912
20190912200438
ACCESSION NUMBER: 0001567619-19-018220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190910
FILED AS OF DATE: 20190912
DATE AS OF CHANGE: 20190912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krainer Adrian R.
CENTRAL INDEX KEY: 0001780081
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38938
FILM NUMBER: 191091376
MAIL ADDRESS:
STREET 1: C/O STOKE THERAPEUTICS, INC.
STREET 2: 45 WIGGINS AVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Stoke Therapeutics, Inc.
CENTRAL INDEX KEY: 0001623526
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471144582
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 PRESTON COURT
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-430-8200
MAIL ADDRESS:
STREET 1: 3 PRESTON COURT
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141028
4
1
doc1.xml
FORM 4
X0306
4
2019-09-10
0
0001623526
Stoke Therapeutics, Inc.
STOK
0001780081
Krainer Adrian R.
C/O STOKE THERAPEUTICS, INC.
45 WIGGINS AVENUE
BEDFORD
MA
01730
1
0
0
0
Director Stock Option (Right to Buy)
28.80
2019-09-10
4
A
0
14777
0
A
2029-09-09
Common Stock
14777
14777
D
This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date.
/s/Stephen Tulipano, Attorney-in-Fact
2019-09-12